 |
|
|
Mesothelioma - Featured Clinical Trials The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
1. Combining Targeted Therapies for Thoracic Cancers
(Posted: 09/26/2006) - In this trial, patients with advanced thoracic cancers (cancers of the chest) or other cancers that have spread to the chest will be treated with the drugs romidepsin and flavopiridol. Researchers will study the safety of this combination and how these agents affect gene and protein expression in these patients.
2. Chemotherapy and Biological Therapy for Advanced Mesothelioma
(Posted: 07/05/2005) - In this study, researchers are adding a biological agent called bevacizumab (Avastin®) to chemotherapy to see if it can help delay the progression of mesothelioma in patients with advanced mesothelioma.
3. Immunotoxin Therapy for Advanced Solid Tumors
(Posted: 09/21/2004) - Researchers with this trial will test the safety of a new drug called SS1(dsFv)-PE38 (SS1P) in patients who have advanced mesothelin-expressing cancers.
|
|
|
